Status:

COMPLETED

Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction

Lead Sponsor:

The University of Hong Kong

Conditions:

Heart Failure With Preserved Ejection Fraction

Eligibility:

All Genders

Phase:

NA

Brief Summary

This is a prospective study that aims to define the utility of cardiac magnetic resonance feature tracking (CMR-FT) as a non-invasive quantification tool to assess diastolic functionality in patients ...

Detailed Description

Despite the increasing prevalence and poor prognosis of HFpEF worldwide, it is facing diagnostic challenges due to its non-specific clinical manifestations. Currently, echocardiography serves as the m...

Eligibility Criteria

Inclusion

  • Patients presenting with symptoms and signs suggestive of HFpEF
  • Patients undergoing coronary catheterisation for stable chest pain with no evidence of diastolic dysfunction, heart failure, infarct, left ventricular ejection fraction \<50% or significant coronary artery disease (ie. \>50% narrowing of one or more coronary arteries)
  • Volunteers must be asymptomatic with no cardiac risk factors and no previous cardiac history

Exclusion

  • Patients suspected to have HFpEF but echocardiography and/or invasive pressure measurements do not confirm diagnosis of HFpEF.
  • Significant underlying ischaemia based on clinical history and non-invasive imaging or catheter coronary angiography if indicated.
  • Contraindication to CMR study
  • Estimated glomerular filtration rate \<30 ml/min/1.73 m2
  • More than moderate valvular disease
  • Severe pulmonary disease (ie. FEV1 \<- 50% predicted)
  • Cardiomyopathy
  • Constrictive pericarditis

Key Trial Info

Start Date :

June 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

172 Patients enrolled

Trial Details

Trial ID

NCT04063579

Start Date

June 1 2018

End Date

December 31 2021

Last Update

May 10 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Hong Kong

Hong Kong, Hong Kong